CAPEX Drug Patent Profile
✉ Email this page to a colleague
When do Capex patents expire, and what generic alternatives are available?
Capex is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in CAPEX is fluocinolone acetonide. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capex
A generic version of CAPEX was approved as fluocinolone acetonide by FOUGERA PHARMS INC on December 16th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CAPEX?
- What are the global sales for CAPEX?
- What is Average Wholesale Price for CAPEX?
Summary for CAPEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Patent Applications: | 4,822 |
| Drug Prices: | Drug price information for CAPEX |
| What excipients (inactive ingredients) are in CAPEX? | CAPEX excipients list |
| DailyMed Link: | CAPEX at DailyMed |
US Patents and Regulatory Information for CAPEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | CAPEX | fluocinolone acetonide | SHAMPOO;TOPICAL | 020001-001 | Aug 27, 1990 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
